Suppliers / Opella Healthcare Brazil Ltda

Opella Healthcare Brazil Ltda

France Updated 9 July 2026

Opella Healthcare Brazil Ltda is a finished-dose manufacturer based in France. It appears in 909 regulatory filings across 31 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), EMA and ANSM (FR). Its GMP standing is certified by ANSM (FR), ANVISA (Brazil) and HSA (SG), among 6 authorities.

0
active US DMFs
0
valid CEPs
11
registered plants
909
filings across 31 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Origgio (VA), United Arab Emirates Not on file
Compiegne, United Arab Emirates Not on file
SUZANO, Brazil Not on file
Risch, Switzerland Not on file
Suzano (Estado De Sao Paulo), Colombia Not on file
Compiegne, France Not on file

5 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 218 None
EMA 170 3
ANSM (FR) 68 10
INFARMED (PT) 67 None
ANVISA (Brazil) 57 4
AEMPS (ES) 50 None
HSA (SG) None 3
INVIMA (CO) None 1
NAFDAC (NG) None 1

Scale

Year Revenue Exports Destinations
2023 $230.0B Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Opella Healthcare Brazil Ltda comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported